Gates Foundation’s BioNTech BNTX Stock Holding History

Gates Foundation’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$17.7M	Hold	148,674	–	–	40.59%	1
2024 Q2	$11.9M	Hold	148,674	–	–	29.71%	2
2024 Q1	$13.7M	Hold	148,674	–	–	16.3%	3
2023 Q4	$15.7M	Hold	148,674	–	–	17.46%	2
2023 Q3	$16.2M	Hold	148,674	–	–	19.26%	2
2023 Q2	$16M	Hold	148,674	–	–	12.77%	4
2023 Q1	$18.5M	Hold	148,674	–	–	16.35%	3
2022 Q4	$22.3M	Hold	148,674	–	–	17.21%	3
2022 Q3	$20.1M	Hold	148,674	–	–	15.89%	3
2022 Q2	$22.2M	Hold	148,674	–	–	17.06%	3
2022 Q1	$25.4M	Hold	148,674	–	–	13.66%	4
2021 Q4	$38.3M	Hold	148,674	–	–	11.62%	4
2021 Q3	$40.6M	Sell	148,674 -890,000	-86%	-$283M	11.89%	3
2021 Q2	$233M	Hold	1,038,674	–	–	35.8%	1
2021 Q1	$113M	Hold	1,038,674	–	–	18.56%	3
2020 Q4	$85M	Buy	+1,038,674	New	+$102M	19.42%	2

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gates Foundation's BNTX Position: Q3 2024 in Review

Gates Foundation held its BioNTech (BNTX) position steady in Q3 2024 at 148,674 shares worth $17.7M. The position accounts for 40.59% of the portfolio, ranked #1.

Gates Foundation first reported a position in BNTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $233M in Q2 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

Gates Foundation held 148,674 shares of BioNTech worth $17.7M as of Q3 2024.
Gates Foundation left its BioNTech share count unchanged in Q3 2024.
BioNTech made up 40.59% of Gates Foundation's portfolio in Q3 2024, its #1 holding.
Gates Foundation first reported a position in BioNTech in Q4 2020 and has held it in 16 quarters since.
Gates Foundation's BioNTech position peaked at $233M in Q2 2021.
296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Gates Foundation's 13F filing for Q3 2024, filed 14 Nov 2024.